SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009735
Filing Date
2022-05-12
Accepted
2022-05-12 16:40:01
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20220512.htm   iXBRL 8-K 58235
2 EX-99.1 crnx-ex99_1.htm EX-99.1 133157
3 GRAPHIC img113038668_0.jpg GRAPHIC 20740
  Complete submission text file 0000950170-22-009735.txt   349017

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20220512.xsd EX-101.SCH 2498
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20220512_pre.xml EX-101.PRE 9938
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20220512_lab.xml EX-101.LAB 13438
8 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20220512_htm.xml XML 4728
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 22918520
SIC: 2834 Pharmaceutical Preparations